Literature DB >> 11435591

Phage display of adenovirus type 5 fiber knob as a tool for specific ligand selection and validation.

A Pereboev1, L Pereboeva, D T Curiel.   

Abstract

Adenovirus (Ad) vectors are most potent for use as gene delivery vehicles to infect human cells in vitro and in vivo with high efficiency. The main limitation in utilization of Ad as a gene transfer vector is the lack of specificity. Genetic modifications of Ad capsid proteins resulting in incorporation of foreign polypeptide ligand sequences can redirect the vector towards target cells. However, in many cases the incorporated ligands lose specificity or lead to conformational changes influencing virion integrity. In order to select target-specific ligands a priori structurally compatible with Ad, we propose a system for displaying polypeptide sequences in the context of the Ad fiber knob on the surfaces of filamentous bacteriophages. To establish this concept, we displayed the wild-type Ad serotype 5 knob and knobs containing c-Myc epitopes and six-histidine sequences in the pJuFo phage system. The knobs remained trimeric and bound the coxsackievirus-Ad receptor, and the phage knob-displayed ligands recognized and bound their cognates in the phage-displayed knob context. Further development of this system may be useful for candidate ligand fidelity and Ad structural compatibility validation prior to Ad modification.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435591      PMCID: PMC114439          DOI: 10.1128/JVI.75.15.7107-7113.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

Review 1.  Strategies to adapt adenoviral vectors for targeted delivery.

Authors:  D T Curiel
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

Review 2.  Update on adenovirus and its vectors.

Authors:  W C Russell
Journal:  J Gen Virol       Date:  2000-11       Impact factor: 3.891

3.  Molecular adaptors for vascular-targeted adenoviral gene delivery.

Authors:  M Trepel; M Grifman; M D Weitzman; R Pasqualini
Journal:  Hum Gene Ther       Date:  2000-09-20       Impact factor: 5.695

4.  Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity.

Authors:  S S Hong; A Galaup; R Peytavi; N Chazal; P Boulanger
Journal:  Hum Gene Ther       Date:  1999-11-01       Impact factor: 5.695

5.  Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells.

Authors:  I Dmitriev; E Kashentseva; B E Rogers; V Krasnykh; D T Curiel
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Targeting of adenoviral vectors through a bispecific single-chain antibody.

Authors:  H J Haisma; J Grill; D T Curiel; S Hoogeland; V W van Beusechem; H M Pinedo; W R Gerritsen
Journal:  Cancer Gene Ther       Date:  2000-06       Impact factor: 5.987

7.  Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium.

Authors:  H Xia; B Anderson; Q Mao; B L Davidson
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo.

Authors:  P N Reynolds; K R Zinn; V D Gavrilyuk; I V Balyasnikova; B E Rogers; D J Buchsbaum; M H Wang; D J Miletich; W E Grizzle; J T Douglas; S M Danilov; D T Curiel
Journal:  Mol Ther       Date:  2000-12       Impact factor: 11.454

9.  The sequence of adenovirus fiber: similarities and differences between serotypes 2 and 5.

Authors:  J Chroboczek; B Jacrot
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

10.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface.

Authors:  G P Smith
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

View more
  5 in total

1.  General strategy for broadening adenovirus tropism.

Authors:  Laura Fontana; Maurizio Nuzzo; Lorena Urbanelli; Paolo Monaci
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

2.  Selection of muscle-binding peptides from context-specific peptide-presenting phage libraries for adenoviral vector targeting.

Authors:  Debadyuti Ghosh; Michael A Barry
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 3.  Transductional targeting of adenovirus vectors for gene therapy.

Authors:  J N Glasgow; M Everts; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-27       Impact factor: 5.987

Review 4.  Molecular engineering of viral gene delivery vehicles.

Authors:  David V Schaffer; James T Koerber; Kwang-il Lim
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

5.  HIV antigen incorporation within adenovirus hexon hypervariable 2 for a novel HIV vaccine approach.

Authors:  Qiana L Matthews; Aiman Fatima; Yizhe Tang; Brian A Perry; Yuko Tsuruta; Svetlana Komarova; Laura Timares; Chunxia Zhao; Natalia Makarova; Anton V Borovjagin; Phoebe L Stewart; Hongju Wu; Jerry L Blackwell; David T Curiel
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.